CVS Health Total Non-Cash Items 2010-2024 | CVS

CVS Health annual/quarterly total non-cash items history and growth rate from 2010 to 2024. Total non-cash items can be defined as the total of all non-cash charges adjusting Net Income on the Cash Flows Statement
  • CVS Health total non-cash items for the quarter ending December 31, 2024 were $4.412B, a 12.51% decline year-over-year.
  • CVS Health total non-cash items for the twelve months ending December 31, 2024 were $11.469B, a 8.12% decline year-over-year.
  • CVS Health annual total non-cash items for 2024 were $4.412B, a 12.51% decline from 2023.
  • CVS Health annual total non-cash items for 2023 were $5.043B, a 0.22% increase from 2022.
  • CVS Health annual total non-cash items for 2022 were $5.032B, a 21.61% decline from 2021.
CVS Health Annual Total Non-Cash Items
(Millions of US $)
2024 $4,412
2023 $5,043
2022 $5,032
2021 $6,419
2020 $5,514
2019 $4,718
2018 $9,573
2017 $1,800
2016 $3,493
2015 $2,056
2014 $2,559
2013 $1,925
2012 $2,122
2011 $1,794
2010 $1,649
2009 $1,602
Sector Industry Market Cap Revenue
Medical Medical Services $81.986B $372.809B
CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $143.728B 26.96
Elevance Health (ELV) United States $94.145B 12.15
Cencora (COR) United States $53.983B 18.77
Natera (NTRA) United States $21.477B 0.00
DiDi Global (DIDIY) China $21.462B 32.57
BioMerieux (BMXMF) France $15.263B 0.00
Solventum (SOLV) United States $12.941B 13.70
EUROFINS SCIENT (ERFSF) Luxembourg $12.036B 0.00
Revvity (RVTY) United States $11.610B 19.98
Doximity (DOCS) United States $11.396B 59.26
ICON (ICLR) Ireland $11.324B 10.53
CochLear (CHEOY) Australia $11.195B 0.00
Viatris (VTRS) United States $10.516B 3.61
Medpace Holdings (MEDP) United States $9.017B 23.95
Avantor (AVTR) United States $8.859B 12.87
HealthEquity (HQY) United States $8.361B 41.13
Sonic Healthcare (SKHHY) Australia $8.215B 0.00
Charles River Laboratories (CRL) United States $7.027B 13.77
Amplifon S.p.A (AMFPF) Italy $4.966B 26.21
Bausch + Lomb (BLCO) Canada $4.202B 24.77
BrightSpring Health Services (BTSG) United States $3.894B 36.05
Sotera Health (SHC) United States $3.832B 21.77
Surgery Partners (SGRY) United States $2.982B 38.77
Alignment Healthcare (ALHC) United States $2.952B 0.00
Concentras Parent (CON) United States $2.771B 16.01
Organon (OGN) United States $2.264B 2.41
Ardent Health Partners (ARDT) United States $2.121B 9.04
Premier (PINC) United States $2.101B 14.38
Progyny (PGNY) United States $1.886B 41.51
PACS (PACS) United States $1.698B 0.00
GeneDx Holdings (WGS) United States $1.683B 64.83
GoodRx Holdings (GDRX) United States $1.669B 31.07
Teladoc Health (TDOC) United States $1.289B 0.00
Pediatrix Medical (MD) United States $1.234B 9.39
Agilon Health (AGL) United States $1.229B 0.00
Establishment Labs Holdings (ESTA) $1.000B 0.00
Ryman Healthcare (RYHTY) New Zealand $0.998B 0.00
CareDx (CDNA) United States $0.911B 14.23
AMN Healthcare Services Inc (AMN) United States $0.866B 8.11
Embecta (EMBC) United States $0.725B 4.89
QDM (QDMI) Hong Kong, SAR China $0.690B 0.00
Nutex Health (NUTX) United States $0.689B 13.50
Enhabit (EHAB) United States $0.530B 43.58
InnovAge Holding (INNV) United States $0.513B 0.00
Auna S.A (AUNA) Luxembourg $0.513B 13.59
Sonida Senior Living (SNDA) United States $0.512B 0.00
LifeMD (LFMD) United States $0.389B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.363B 0.00
SBC Medicals (SBC) United States $0.359B 0.00
Beauty Health (SKIN) United States $0.220B 0.00
Performant Healthcare (PHLT) United States $0.202B 0.00
Oncology Institute (TOI) United States $0.193B 0.00
DocGo (DCGO) United States $0.147B 24.08
Sera Prognostics (SERA) United States $0.087B 0.00
So-Young (SY) China $0.087B 0.00
Basel Medical Group (BMGL) Singapore $0.087B 0.00
KindlyMD (KDLY) United States $0.082B 0.00
OncoCyte (OCX) United States $0.080B 0.00
Ascend Wellness Holdings (AAWH) United States $0.076B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.054B 0.00
Biodesix (BDSX) United States $0.053B 0.00
Pheton Holdings (PTHL) China $0.031B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.030B 0.00
ModivCare (MODV) United States $0.018B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
Co-Diagnostics (CODX) United States $0.011B 0.00
Intelligent Bio Solutions (INBS) United States $0.008B 0.00
BioNexus Gene Lab (BGLC) $0.006B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00